Amneal Pharmaceuticals, Inc. AMRX Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s non-controlling interests?
- Amneal Pharmaceuticals, Inc. (AMRX) reported non-controlling interests of -$558K in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s non-controlling interests changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s non-controlling interests decreased by 67.6% year-over-year, from -$333K to -$558K.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s non-controlling interests?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s non-controlling interests has grown at a -58.1% compound annual growth rate (CAGR), from $41.66M to -$535K.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.